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Abstract
Background: The transfection of human mesenchymal stem cells (hMSCs) with the hyperpolarization-activated
cyclic nucleotide-gated ion channel 2 (HCN2) gene has been demonstrated to provide biological pacing in
dogs with complete heart block. The mechanism appears to be the generation of the ion current (If) by the
HCN2-expressing hMSCs. However, it is not clear how the transfection process and/or the HCN2 gene affect the
growth functions of the hMSCs. Therefore, we investigated survival, proliferation, cell cycle, and growth on a
Kapton® scaffold of HCN2-expressing hMSCs.
Methods: hMSCs were isolated from the bone marrow of healthy volunteers applying a selective cell adhesion
procedure and were identified by their expression of specific surface markers. Cells from passages 2–3 were
transfected by electroporation using commercial transfection kits and a pIRES2-EGFP vector carrying the
pacemaker gene, mouse HCN2 (mHCN2). Transfection efficiency was confirmed by enhanced green fluorescent
protein (EGFP) fluorescence, quantitative real-time polymerase chain reaction (RT-qPCR) and enzyme-linked
immunosorbent assay (ELISA). After hMSCs were transfected, their viability, proliferation, If generation, apoptosis,
cell cycle, and expression of transcription factors were measured and compared with non-transfected cells and
cells transfected with pIRES2-EGFP vector alone.
Results: Intracellular mHCN2 expression after transfection increased from 22.14 to 62.66 ng/mg protein (p < 0.05).
Transfection efficiency was 45 ± 5 %. The viability of mHCN2-transfected cells was 82 ± 5 %; they grew stably for more
than 3 weeks and induced If current. mHCN2-transfected cells had low mitotic activity (10.4 ± 1.24 % in G2/M and
83.6 ± 2.5 % in G1 phases) as compared with non-transfected cells (52–53 % in G2/M and 31–35 % in G1 phases).
Transfected cells showed increased activation of nine cell cycle-regulating transcription factors: the most
prominent upregulation was of AMP-dependent transcription factor ATF3 (7.11-fold, p = 0.00056) which regulates
the G1 phase. mHCN2-expressing hMSCs were attached and made anchorage-dependent connection with other
cells without transmigration through a 12.7-μm thick Kapton® HN film with micromachined 1–3 μm diameter pores.
Conclusions: mHCN2-expressing hMSCs preserved the major cell functions required for the generation of biological
pacemakers: high viability, functional activity, but low proliferation rate through the arrest of cell cycle in the G1 phase.
mHCN2-expressing hMSCs attached and grew on a Kapton® scaffold without transmigration, confirming the relevance
of these cells for the generation of biological pacemakers.
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Background
Electronic pacing is the state-of-the art treatment for
complete heart block and a variety of other cardiac ar-
rhythmias. While they successfully regulate heart rhythm,
electronic pacemakers are not without risk, including in-
fection, lead fracture and displacement, and potential
interference from other devices. These concerns plus the
need for frequent monitoring and for battery replacement
have led to a search for other means—such as biological
pacemakers—to provide cardiac pacing.
Some of these other means reported to provide bio-
logical pacing are virally delivered gene therapies aimed
at increasing inward and or decreasing outward ionic
currents during diastole, the use of transcription factors
to convert mature myocytes into sinus node-like cells,
and the use of embryonic stem cells (ESCs) or induced
pluripotent stem cells (iPSCs) converted into a pace-
maker lineage [1–5]. Another approach used mesenchy-
mal stem cells (MSCs) and a self-inactivating HIV-based
lentiviral vector for delivery of human potassium/sodium
hyperpolarization-activated cyclic nucleotide-gated ion
channel 2 (HCN2) into rabbit MSCs [6]. Bone marrow
(BM)-derived human mesenchymal stem cells (hMSCs)
transfected with the mouse HCN2 (mHCN2) gene were
grafted to initiate a biological rhythm in the canine heart
[7]. However, the MSCs have been shown to migrate away
from the administration site within weeks of engraftment,
making this a short-term solution. This problem might
solved by trapping HCN2-expressing and heart rhythm-
stimulating cells in cages/scaffolds thus preventing trans-
migration, preserving their long-term growth, sufficient
nutrition and functional properties. Additionally, cell
functions such as viability, stability, and renewal rate of
HCN2-transfected cells are important factors.
Therefore, in the present study we explored the rele-
vance of mHCN2-expressing hMSCs for the generation
of biological pacemakers, paying particular attention to
cell proliferation and cell cycle regulation and to the
ability of mHCN2-transfected cells to grow and function
on the porous Kapton® scaffold.
Methods
Isolation and expansion of BM-derived hMSCs
hMSCs were isolated, identified, and expanded from BM
aspirates following previously described protocols [8, 9].
Briefly, BM aspirates (~6 ml) from the iliac crest of
humans (up to 40 years old) were collected after obtain-
ing written informed consent according to the Declar-
ation of Helsinki and approval by the Lithuanian
Bioethics Committee (No. 158200-14-741-257). BM do-
nors were tested according to guidelines for the prepar-
ation of blood and blood products. Unprocessed bone
marrow was seeded at a density of 12,000 mononuclear
cells (MNC)/cm2 in T-75 flasks (NUNC, Wiesbaden,
Germany) and cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10 % fetal bovine serum
(FBS) at 37 °C in a humidified atmosphere of 5 % CO2.
After 24 h, supernatant containing non-adherent cells
was removed, cells were rinsed with phosphate-buffered
saline (PBS) without Ca2+/Mg2+ (Biochrom, UK) and
growth medium was added. Additional changes of growth
medium were performed every 3 days. For further experi-
ments, cells were used from passages 2–3. Only the MSCs
that corresponded to all main MSC identification criteria
were included in the study.
Transfection of hMSC with the mHCN2 gene
A full-length of mHCN2 cDNA, subcloned in a pIRES2-
EGFP vector (BD Biosciences Clontech, San Jose, USA),
was transfected into the hMSCs by electroporation using
the Lonza 4D-Nucleofector™ system (Lonza, USA).
hMSCs were transfected with 3 μg pIRES2-EGFP and
pIRES2-mHCN2-EGFP vectors, and the efficiency of
transfection was estimated by the number of green
fluorescence-emitting cells (enhanced green fluorescence
protein (EGFP) excitation 488 nm, emission 509 nm). The
total number of green fluorescent cells 24–48 h after the
incorporation of vectors revealed 40–50 % transfection ef-
ficiency. Transfected cells were cultured in hMSC growing
medium (Poietics MSCGM, BioWhittaker, Lonza) at 37 °C
in a 5 % CO2 humidified atmosphere. To select a pure
population of mHCN2-expressing hMSCs, cells were
exposed to 50 μM geneticin for an additional 5 days.
Transfection efficiency was also confirmed by both quan-
titative real-time polymerase chain reaction (RT-qPCR)
and enzyme-linked immunosorbent assay (ELISA).
Investigation of mHCN2 expression by RT-qPCR
pIRES-EGFP- and pIRES-mHCN2-EGFP-transfected hMSCs
were lysed, and their RNA was extracted and purified
using RNeasy Mini Spin columns (Qiagen, USA) accord-
ing to the manufacturer’s instructions. RNA concentration
and purity were evaluated with a SpectraMAX i3 spectro-
photometer (Molecular Devices, USA). RNA samples
were treated with DNase I (Thermo Scientific™) and re-
versely transcribed with the Maxima®First Strand cDNA
Synthesis Kit (Thermo Scientific™) according to the manu-
facturer’s protocols. PCRs were performed using Maxima®
Probe qPCR Master Mix (2×) (Thermo Scientific™) and
Stratagene MX-3005P detection instrument (Agilent
Technologies, USA). The TaqMan® Gene Expression
Assays (Applied Biosystems, USA) for HCN2 (human,
Hs00606903_m1), mHCN2 (mouse, Mm00468538_m1),
and ACTB (housekeeping gene, Hs01060665_g1) were
used for gene expression analysis and separation of
endogenous human HCN2 from transfected mHCN2.
Expression of the mHCN2 gene after transfection was
compared with the level of the endogenous human HCN2
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gene in hMSCs (Fig. 1a). All reactions were run in tripli-
cate starting with a denaturation step for 10 min at 95 °C
followed by 40 cycles of 15 s at 95 °C for denaturation and
60 s for annealing and extension. The gene expression ra-
tio (pIRES-mHCN2 vs. non-transfected cells) was calcu-
lated using the 2-ΔΔCt equation. The efficiency of mHCN2
transfection was measured 5 days after the cell growth
with 50 μM geneticin.
Evaluation of mHCN2 protein expression by ELISA
Cells were lysed using three cycles of freezing-thawing.
Before making measurements, all samples were kept on
ice. mHCN2 expression after hMSC transfection was
measured using an ELISA kit for the estimation of
mouse potassium/sodium hyperpolarization-activated
cyclic nucleotide-gated channel 2 (EIAab, cat.
No.E15069m) following the manufacturer’s instructions.
Absorbance was measured at 450 nm using a Spectra-
max plate reader. Three groups of cell lysates were
investigated: pIRES-mHCN2-EGFP-expressing (positive
control), pIRES-EGFP-transfected (control with transfec-
tion reagent), and non-transfected (negative control)
hMSCs. The concentration of total protein in all tested
groups was measured using the Bio-Rad DC Protein Kit
according to the manufacturers’ instructions. Absorb-
ance was read at 750 nm using a Spectramax plate
reader. The final concentration of intracellular mHCN2
after transfection was expressed as ng/mg protein. The
efficiency of mHCN2 protein expression in hMSCs was
measured 5 days after cell growth with 50 μM geneticin.
Patch-clamp and dye transfer measurements
For electrophysiological recordings, glass coverslips with
hMSCs were transferred to the experimental chamber
with constant flow-through perfusion, and mounted on
the stage of an inverted microscope (Olympus IX81).
Junctional conductance between hMSCs (abutted or
connected through tunneling tubes (TT)) was measured
Fig. 1 Efficiency of mouse HCN2 (mHCN2) transfection in hMSCs cells. a Primary evaluation of transfection efficiency by microscopy: upper left
panel, light microscopy picture of hMSCs; upper right panel, fluorescent picture of not transfected cells; lower panel, fluorescent picture of
mHCN2-transfected cells. Cells were investigated 48 h after the seeding. Magnification 20×. b Evaluation of transfection efficiency by flow cytometry.
Red, fluorescence of cells before transfection; blue, fluorescence of cells after transfection. One representative graph is shown. c Expression of the
mHCN2 gene in hMSCs was estimated by RT-qPCR. HCN2 column shows the level of endogenous human HCN2 in hMSCs cells estimated with cDNA
against human HCN2. d Level of intracellular mHCN2 protein after transfection was estimated by ELISA and expressed as ng/mg protein. Protein was
measured as described in the Methods section. Data are presented as means ± SD. The increased mHCN2 expression after transfection was significant
at *p < 0.05
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using the dual whole-cell patch-clamp technique. Cells 1
and 2 of a cell pair were voltage clamped independently
with the patch-clamp amplifier (MultiClamp 700B; Mo-
lecular Devices, Inc., USA) at the same holding potential
(V1 = V2). Voltages and currents were digitized using the
Digidata 1440A data acquisition system (Molecular
Devices, Inc.) and acquired and analyzed using pClamp
10 software (Molecular Devices, Inc.). By stepping the
voltage in cell 1 (ΔV1) and keeping the other constant,
junctional current was measured as the change in
current in the unstepped cell 2, Ij = ΔI2. Thus, gj was ob-
tained from the ratio –Ij/ΔV1, where ΔV1 is equal to
transjunctional voltage (Vj), and a negative sign indicates
that the junctional current measured in cell 2 is oppos-
itely oriented to that measured in cell 1.
To examine whether cells residing on the opposite
sides of Kapton® scaffold can couple through 3 μm diam-
eter pores, non-transfected hMSCs were seeded on one
side of the scaffold and 24 h later the mHCN2-
transfected cells were seeded on the other side of the
scaffold. After the attachment of transfected cells, DAPI
dye (20 μM) was injected through the patch pipette into
the mHCN2-transfected hMSC, and its transfer to the
non-transfected cells residing on the other side of the
scaffold was monitored by time lapse imaging at 37 °C
in a humidified atmosphere of 5 % CO2 using an incuba-
tion system (INUBG2E-ONICS; Tokai Hit, Shizuoka-
ken, Japan) with an incubator mounted on the stage of
the microscope equipped with an Orca-R2 cooled digital
camera (Hamamatsu Photonics K.K., Japan), fluores-
cence excitation system MT10 (Olympus Life Science
Europa Gmbh, Hamburg, Germany), and XCELLENCE
software (Olympus Soft Imaging Solutions Gmbh,
München, Germany).
Patch pipettes were pulled from borosilicate glass ca-
pillary tubes with filaments. To minimize the effect of
series resistance on the measurements of gj [10], we
maintained pipette resistances below 3 milli-ohms. Patch
pipettes were pulled from borosilicate glass capillary
tubes with filaments. Experiments were performed at
room temperature in Krebs-Ringer solution (mM): NaCl,
140; KCl, 4; CaCl2, 2; MgCl2, 1; glucose, 5; pyruvate, 2;
HEPES, 5 (pH = 7.4). Patch pipettes were filled with in-
ternal solution (mM): KCl, 130; Na aspartate, 10; MgATP,
3; MgCl2, 1; CaCl2, 0.2; EGTA, 2; HEPES, 5 (pH = 7.3).
Patch-clamp measurements were performed 48–72 h after
transfection.
Cell viability-apoptosis assay
The number of viable cells, type of cell, and cell death,
and stage of apoptosis of mHCN2-expressing hMSCs after
selection with geneticin were analyzed using the Muse®
Annexin V & dead cell assay (Merck Millipore) following
the manufacturer’s instructions. This assay allows
quantitative identification of live, early and late apoptotic,
and dead cells by measuring the intensity of cell fluores-
cence. Briefly, cells transfected with the mHCN2 gene,
only, with the pIRES vector, and non-transfected hMSCs
were harvested with trypsin-EDTA and suspended in
DMEM containing 10 % fetal calf serum. Cell suspension
(100 μl) and Muse™ annexin V & dead cell reagent (100 μl;
Annexin V and 7-AAD) were thoroughly mixed. Samples
were incubated for 20 min in the dark. The Muse™ Cell
Analyzer (Merc Millipore) was used to measure cell fluor-
escence. Cells were separated into groups according to the
intensity of green (Annexin; early and late apoptotic cells)
and red (7-AA; dead cells) fluorescence. Cell viability was
tested 5 days after the transfected cell growth with 50 μM
geneticin. Non-transfected cells were grown in parallel for
the same time period.
Measurements of cell proliferation and cell cycle
Proliferation measurements were performed using the
CCK-8 kit (Dojindo Molecular Technologies, USA) ac-
cording to the manufacturer's instructions. Briefly, after
selection with geneticin, mHCN2- and pIRES-transfected
hMSCs were grown for 5 days in 12-well plates. Similar
numbers (25 × 103) of non-transfected hMSCs were
seeded in 12-well plates and allowed to attach for 24 h.
Then, the number of proliferating cells in each cell group
was measured every 24 h by adding a required volume of
CCK-8 reagent with subsequent incubation for 3 h and
measurement of absorption at 450 nm. Proliferation rates
were measured for 72 h. Non-transfected hMSCs were
grown and analyzed in parallel to the transfected ones.
Cell cycle was also measured 72 h after cell growth fol-
lowing the manufacturer’s instructions. Briefly, mHCN2-
and pIRES-transfected, and non-transfected hMSCs were
harvested with trypsin-EDTA. Cells were suspended in
growth media containing 10 % fetal calf serum; 200 μl
cells were added to each tube, centrifuged at 300 × g for 5
min and washed once with PBS. Then cells were sus-
pended in 200 μl ice cold 70 % ethanol and incubated for
3 h at −20 °C. Cells were centrifuged at 300 × g for 5 min
and washed once with PBS; 200 μl Muse™ Cell Cycle Re-
agent was added to each tube and incubated for 30 min at
room temperature in the dark. The cell cycle reagent was
a mixture of propidium iodide (PI) and RNAse A in re-
spective proportions subsequently intercalating nuclear
DNA. The assay allows identification and measurement of
the percentage of cells in each cell cycle phase (G0/G1, S,
and G2/M) according to the intensity of PI-based red
fluorescence. The DNA Muse™ Cell Analyzer program
was used to evaluate the results.
Investigation of transcription factors by RT-qPCR
After selection with geneticin, pIRES-EGFP, pIRES-
mHCN2-EGFP-transfected, and non-transfected hMSCs
Bruzauskaite et al. Stem Cell Research & Therapy  (2016) 7:67 Page 4 of 15
were lysed and RNA was extracted as described above.
RNA was reversely transcribed with the RT2 First Strand
Kit (Qiagen, USA) according to the manufacturer’s proto-
cols. PCRs were performed using RT2 SYBR Green ROX
qPCR Mastermix (Qiagen, USA) and the Stratagene
MX-3005P detection instrument (Agilent Technolo-
gies). The Human Transcription Factors RT2 Profiler™
PCR Array (Qiagen, PAHS-075Z) was used to screen
gene expression changes. Samples of three independent
transfection experiments were investigated. Raw data were
analyzed by the GeneGlobe Data Analysis Center platform
(available online: http://www.qiagen.com/fo/shop/genes-
and-pathways/data-analysis-center-overview-page/; Qiagen,
USA). For the normalization of gene expression, the geo-
metric mean of four threshold cycles (Ct) of reference
genes was used. Gene expression ratio was calculated using
the 2-ΔΔCt equation. Data were statistically significant
at p < 0.05. The expression of transcription factors in
transfected cells was measured after cell growth with
50 μM geneticin for 5 days and compared with non-
transfected hMSCs.
Manufacture of Kapton® scaffold
Pores were micromachined in a commercially available
12.7-μm thickness polyimide Kapton® HN (DuPont,
USA) film using FemtoLab workstation (Workshop of
Photonics) and second harmonic (515 nm) of Yb:KGW
femtosecond laser Pharos (Light Conversion). The diam-
eters of the resulting pores were 1–3 μm, as determined
by scanning electron microscope (Quanta 200 FEG) [11]
under the low-vacuum mode.
Immunocytochemistry
To detect the growth of mHCN2-transfected hMSCs
and their possible transmigration through the Kapton®
scaffold, 4 × 104 non-transfected hMSC were labeled
with PKH26 (red fluorescent cell linker kit; Sigma-
Aldrich) following the manufacturer’s instructions and
seeded on one side of a scaffold. The next day, 4 × 104
mHCN2-transfected hMSCs (green fluorescence of
EGFP) were seeded on the other side of the scaffold,
which was then fixed on a specially designed cell crown
holder. After 24 h of cell growth in media at 37 °C in a
humidified atmosphere with 5 % CO2, cell were washed
and fixed with 4 % paraformaldehyde and mounted in
the Vectashield (Vector Labs, USA) containing DAPI for
visualization of the nuclei. All samples were analyzed
using a Leica TCS SP8 confocal microscope.
Statistical analyses
All statistical analyses were performed using the SPSS
package (version 19.0 for Windows; SPSS Inc., Chicago,
IL, USA) and considered to be significant at the 5 % level.
Differences between transfected and non-transfected cells
were tested by analysis of variance (ANOVA) and Student’s
t test. Data are presented as means ± SD.
Ethical approval
All hMSC isolation procedures were approved by the
Ethics Committee of Vilnius Regional Biomedical Re-
search, Lithuania (No. 158200-14-741-257). All volunteers
gave written consent and agreed with the investigational
procedure of BM.
Results
Efficiency of hMSC transfection
The efficiency of transfection with pIRES2-EGFP and
pIRES2-HCN2-EGFP vectors was evaluated by fluores-
cence microscopy, RT-PCR, and ELISA. Data in Fig. 1a
show that non-transfected cells did not have green fluor-
escence, whereas transfected cells had green fluores-
cence. The efficiency of plasmid incorporation has also
been confirmed by flow cytometry (Fig. 1b). mHCN2
gene expression was also confirmed by RT-PCR (Fig. 1c).
mHCN2 protein expression was investigated by ELISA
and expressed as ng/mg protein (Fig. 1d). Representative
profiles of cell population and apoptosis of mHCN2-
transfected cells analyzed by Muse™ Annexin V and
Dead cell reagent is demonstrated in Fig. 2a. The per-
centage of early, late, and total apoptosis in cells from
three independent transfection experiments is shown in
Fig. 2b. Induction of necrosis after transfection was neg-
ligible. Cells transfected with the pIRES2-EGFP and with
the pIRES2-mHCN2-EGFP vectors showed similar levels
of live, early, and late apoptosis, which suggests that cell
apoptosis was induced by the electroporation procedure,
which could damage cell membranes, rather than by the
mHCN2 gene itself.
If and cell to cell coupling
The expression of functional mHCN2 channels and elec-
trical coupling between abutted hMSCs (Fig. 3A) or
hMSCs connected through tunneling nanotubes (TNTs)
(Figs. 3B and C) were examined by dual whole-cell
patch-clamp measurements. The co-culture of mHCN2-
transfected (green) and control hMSCs (not fluorescent)
was investigated. TNTs formed by the lamellipodium
outgrowth mechanism formed the gap junction (GJ)-
based electrical coupling between the hMSCs that also
could be achieved by intersection of lamellipodia exten-
sions (inset c). TNTs between hMSCs contained F-actin
and Cx43 GJs at the interface of hMSC-1 and the la-
mellipodium ending of hMSC-2 (Fig. 3D and inset d).
Non-transfected hMSCs did not exhibit time-
dependent hyperpolarization (Fig. 3E, upper panel) acti-
vated current If (Fig. 3E, middle panel), whereas mHCN2
expressing hMSCs showed If current (Fig. 3E, lower
panel). In the mHCN2-transfected hMSCs, If was nearly
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fully activated at −140 mV (504 ± 130 pA; n = 4) with an
activation threshold of −90 mV. Fig. 3F (lower panel) dis-
plays the gj/Vj plot obtained by measuring the Ij response
(Fig. 3F, middle panel) in the hMSC-2 to the voltage ramp
(Fig. 3F, upper panel) applied to the hMSC-1 with its sym-
metric counterpart at positive Vjs. The presence of voltage
gating indicates that the cells established electrical coup-
ling by forming functional GJs. The measured gj between
six abutted cell pairs was 37.14 ± 3.61 nS and gT between
five cell pairs connected through TNTs was 1.15 ± 0.25 nS.
Cell cycle of mHCN2-expressing hMSCs
Both types of transfected cells (with empty pIRES vec-
tor and with mHCN2 gene) showed significantly
downregulated proliferation rates compared to the
non-transfected hMSCs (Fig. 4a). Moreover, the
mHCN2-transfected cells showed significantly lower
proliferation rates compared to the pIRES-transfected
cells (Fig. 4a). This finding led us to analyze the cell
cycle and possible mechanisms involved in its regula-
tion. Data in Fig. 4b show representative population
and DNA content of one mHCN-2 transfection experi-
ment, whereas data in Fig. 4c demonstrate summarized
data from three independent transfection experiments
compared to the non-transfected cells. mHCN2- and
pIRES-transfected hMSCs were significantly concen-
trated in the G1 phase with low numbers of cells in
G2/M phase, whereas non-transfected hMSCs had an
Fig. 2 Measurement of apoptosis in transfected and non-transfected hMSCs. a Representative profiles of cell population (left) and apoptosis (right)
of mHCN2-transfected cells. b Quantitative viability and apoptosis of non-transfected hMSCs (negative control), pIRES-EGFP (pIRES control) and
pIRES-mHCN2-EGFP (mHCN2-transfected cells; Hcn2-expressing) transfected hMSCs. Data are presented as means ± SD from three independent
transfection experiments. Transfected cells were investigated by Muse® equipment 5 days after their growth with 50 μM geneticin.
Non-transfected cells grew and were investigated in parallel. The induction of apoptosis in transfected compared to non-transfected cells
was statistically insignificant
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Fig. 3 (See legend on next page.)
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almost equal distribution between G1 and G2/M phases
(Fig. 4c). The mHCN2-expressing cells showed slightly
stronger downregulation of the cell cycle compared to the
pIRES-transfected cells. Cell cycle of transfected cells was
measured after selection by 50 μM geneticin.
Transcription factors regulating cell cycle of
mHCN2-expressing hMSCs
Data from the cell cycle experiments inspired us to in-
vestigate further mechanisms regulating the cell cycle
after transfection. For this purpose, we investigated an
(See figure on previous page.)
Fig. 3 Current generation by mHCN2-expressing cells and their electrical coupling. Human mesenchymal stem cells (hMSCs) expressing mHCN2
(green) abutted (a) and connected through tunneling nanotubes (TNTs) (b, c). (inset c) GJ-based electrical coupling between cells also could be
achieved by intersection of lamellipodia extensions. d and inset d TNTs between hMSCs containing F-actin, and Cx43-based GJs between
hMSC-1 and the lamellipodium of hMSC-2. If current was measured in mHCN2-expressing hMSCs (e, lower panel) by hyperpolarizing the cells from
Vh = −40 mV for 5 s to voltages between −50 and −140 mV in 10 mV increments (e, upper panel). If current was absent in non-transfected or
transfected with empty vector hMSCs (e, middle panel). f Typical experiment showing the measurement of electrical coupling between two
hMSCs connected through TNT (shown in b). gT/VT plot (f, lower panel) was obtained by measuring the Ij response (f, middle panel) in the hMSC-2 to
the voltage ramp of negative polarity from 0 to −120 mV (f, upper panel) applied to the hMSC-1 with its symmetric counterpart at positive Vjs. The
co-culture of mHCN2-transfected (green fluorescence) and non-transfected hMSCs (not fluorescent) was investigated
Fig. 4 Proliferation and cell cycle of transfected and non-transfected hMSCs. a Proliferation rate of non-transfected (negative control), pIRES-EGFP-
transfected (pIRES control) and pIRES-mHCN2-EGFP-transfected (mHCN2-transfected) hMSCs over 72 h. Control, pIRES-, and mHCN2-transfected cells
were investigated after their growth with geneticin for 5 days. Changes in proliferation rate were significant (p < 0.05) compared to the
non-transfected cells. b Representative profiles of cell population (left) and DNA content (right) of mHCN2-transfected hMSCs. c Summarized
quantitative percentage of each cell cycle phase. Data are presented as means ± SD. *Data were significant compared to the negative control
at p < 0.05. Proliferation of transfected cells was measured 5 days after their growth with geneticin (50 μM). Non-transfected cells grew for 72 h and
were analyzed in parallel. Data are presented as means ± SD
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array of transcription factors and their changes after
both types of transfection (pIRES and mHCN2) com-
pared with non-transfected hMSCs. Data presented in
Fig. 5 show changes in expression of transcription fac-
tors measured in pIRES- and mHCN2-transfected cells
compared to the negative control (non-transfected
hMSCs). Further statistical analysis of PCR data revealed
that mHCN2-transfected cells significantly upregulated
nine transcription factors involved in cell cycle regula-
tion compared to the pIRES-transfected cells (Table 1).
It also demonstrates that the activation of the nine
transcription factors is a result of the mHCN2 gene and
not the transfection procedure. The most significantly
upregulated factor in mHCN2-transfected cells was
activating transcription factor ATF3, a member of the
cAMP response element-binding (CREB) protein family
of transcription factors (7.11-fold, p = 0.00056). Other
cell cycle regulating transcription factors were upregu-
lated from 1.6- to 2.97-fold (p < 0.05; Table 1).
Growth of mHCN2-expressing cells on porous scaffold
Stem cells directly grafted into heart tissue or injected
through the vessels may be released due to the strong
contraction of heart muscle or as a response to signaling
molecules. Therefore, we investigated the possibility of
enclosing cells in a cage/scaffold with particular pore
sizes that could be impermeable for cells but allow pass-
ing of nutrients and/or anchorage-dependent cell to cell
Fig. 5 Panels of changed activities of transcription factor arrays after transfection. Folds of change in activities of transcription factors after pIRES- and
mHCN2-transfections were compared to non-transfected cells. Data are presented as mean values of fold-changes obtained during three independent
experiments. The statistically significant activation of nine transcription factors after mHCN2 transfection compared to pIRES transfection is presented
in Table 1
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communication. Data from other authors showed that
the best pore size for cell growth without transmigration
through the scaffold could be up to 3 μm in diameter
[12]. With this in mind, we investigated 8.9–16.5 μm
thick Kapton® scaffold with 1–3 μm pores of conical
shape. Data in Fig. 6 show that mHCN2-expressing cells
were able to attach and grow on the Kapton® scaffold
without transmigration. Confocal micrographs demon-
strate that the same mHCN2-transfected cells were able
to grow on one side (Fig. 6a-d) and non-transfected
hMSCs stained with PKH26 on the other side of scaffold
(Fig. 6e). Both types of the above-mentioned cells could
grow on different sides of the scaffold without transmi-
gration (Fig. 6f ). Moreover, the mHCN2-expressing
hMSCs growing on the one side of the Kapton® scaffold
(cell 1 in Fig. 7a; nucleus encircled in Fig. 7c) can estab-
lish the intercellular communication with the non-
transfected hMSCs growing on the other side of the
scaffold (cells 2 and 3 in Fig. 7b; nuclei encircled in
Fig. 7c). DAPI dye injected through the patch pipette
into cell 1 was transferred to cells 2 and 3, confirming
that cells residing on the opposite sides of the scaffold
can couple to each other through 3-μm pores. Note that
nucleus staining in the DAPI-injected cell 1 is not visible
because the Kapton® scaffold is impermeable to the UV
light used for excitation of DAPI fluorescence, while nu-
clei staining in the recipient cell 2 and cell 3 are obvious,
and DAPI accumulation kinetics in these cells is shown
in Fig. 7d.
Discussion
The major requirements for generating functional bio-
logical pacemakers are construction of viable, properly
functioning and proliferating cells capable of generating
the pacemaker current and growing on the porous
scaffolds. In this study, we have demonstrated that
mHCN2-transfected hMSCs expressed the mHCN2
channel protein and exhibited If current necessary for
cardiac stimulation. However, the capacitances of trans-
fected hMSCs varied from 100 to 200 pF, and If densities
in our experiments were limited to several pA/pF. This
was presumably due to insufficient translation and/or
not completed insertion of mHCN2 channels into the
cell membrane after transfection. The mHCN2-
transfected MSCs preserved their viability, generated
pacemaker current, grew on the porous Kapton® scaf-
folds with 1–3 μm diameter pore arrays, and established
intercellular communication between opposite sides of
the scaffold without transmigration through the pores.
The polyimide films demonstrated suitable mechanical
and thermal properties, and good biocompatibility, and
have already been successfully applied to a vast range of
biomedical investigations [13–17]. In parallel to the for-
mation of functionally active HCN channels, the mHCN2-
transfected MSCs expressed Cx43 necessary for commu-
nication through Cx43-based GJ channels and F-actin
containing TNTs necessary for the biological pacemaker
functioning. The collaboration of functional GJs and
HCN2 channels as a pacemaker unit in heterologous
cell pairs has been shown elsewhere [18].
Importantly, data from this study show, for the first
time, that the proliferation rate of mHCN2-transfected
cells was significantly downregulated, mainly by the nine
transcription factors that controlled the cell cycle. Our
findings show mHCN2-expressing hMSCs have low pro-
liferative activity that could be vitally important for the
proper and long-term function of heart-stimulating cells.
Other authors also revealed that quiescence and self re-
newal are critical for stem cell pool preservation and
long-term engraftment potential [19]. Highly proliferat-
ing cells do not have enough time for cell renewal, and
eventually their supply might become exhausted. On
the other hand, given the extracellular stimuli and ful-
fillment of various regenerating functions, stem cells
cannot be quiescent all the time [20]. Data from this
study show that the balance between cell cycle and
functional activity of mHCN2-transfected hMSCs is
important for the biological pacemaker. The ability to
modify the balance between the activation of cell cycle-
regulating transcription factors and HCN channel
Table 1 Statistically evaluated impact of mouse HCN2 to the expression of transcription factors
No Gene Main impact to cell cycle regulation Fold-change P value
1. ATF3 Delays G1 to S transition [29] 7.11 0.00056
2. ETS2 Promotes G2/M phase [46] 2.79 0.02
3. GTF2B Regulates G1 phase [33] 1.9 0.01
4. ID1 Promotes G1/S phase [37] 1.86 0.044
5. MYC Promotes G1/S phase [36] 2.3 0.0028
6. NFATC3 Promotes G1/S phase [41] 1.6 0.02
7. REL Promotes G0 toG1 transition [45] 1.94 0.014
8. TBP Delays G2/M phase [24] 2.04 0.012
9. TGIF1 Promotes G0 toG1 transition [22] 2.97 0.025
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proteins could be a useful tool in the field of biological
pacing.
TG-interacting factor 1 (TGIF1) is a transcriptional re-
pressor and necessary factor modulating the balance be-
tween cell quiescence, self renewal, and differentiation.
TGIF1 knockdown in myeloid progenitors affected cell
proliferation and induced cell cycle blocking at the G0
stage [21]. Another study also showed that TGIF1 knock-
out resulted in increased quiescence of hematopoietic
stem cells, their self-renewal, and a tendency to reside in
the G0 state [22]. On the other hand, the transcription
factor c-Rel protein, a member of the NFkB transcription
factor family, stimulates the cell cycle as well as the vari-
ous other intracellular functions. Binding of NFkB to the
cell DNA is rapidly induced by serum growth factors and
stimulates the G0 to G1 transition in mouse fibroblasts
[23]. Additionally, it was shown that c-rel is also induced
by serum in quiescent fibroblasts and the level of c-rel
transcripts decreases to nearly the basal level 3 h after
stimulation [24]. This finding suggests that c-rel is
Fig. 6 Growth of mHCN2-expressing cells on Kapton® scaffold. a Light microscopy image of mHCN2 cells grown on the Kapton® scaffold. Magnifi-
cation 20×. b Fluorescent image of mHCN2-transfected hMSC grown on the Kapton® scaffold. Magnification 20×. c Confocal three-dimensional
image of mHCN2-transfected cells (green). Magnification 20×. Scale bar 10 μm. d Confocal three-dimensional image of mHCN2-transfected cells
(green) and nucleus (blue). Magnification 20×. Scale bar 10 μm. e Confocal three-dimensional image of non-transfected hMSCs stained with PKH26
(red) and nucleus (blue). Magnification 20×. f Confocal three-dimensional image of mHCN2-transfected cells (green) on the one side of Kapton®
scaffold and hMSC stained with PKH26 (red) on the opposite side. Nuclei were stained blue. Magnification 20×
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involved in the transition from the G0 to G1 phase. C-
Rel was also found in the S phase, whereas its level
decreased when cells entered the G2 phase [25]. Our
data show that increased expression of TGIF1 and c-Rel
by 2.97- and 1.94-fold, respectively, can be responsible
for the advancement of mHCN2-expressing cells from
the G0 stage to further phases of the cell cycle.
The next step in cell cycle regulation is controlled
transition of mHCN2-transfected cells into the G1
phase. This step is strongly regulated by ATF3, which
belongs to the family of CREB transcription factors and
is a stress-inducible gene [26]. ATF3 has an anti-
apoptotic effect and inhibits adriamycin-induced apop-
tosis in primary cardiomyocytes [27]. Furthermore, chick
embryo fibroblasts stably expressing ATF3 grew better
under low serum conditions [28]. It was also shown that
ATF3+/+ fibroblasts more slowly transitioned from the
G1 to S phase, suggesting a growth cycle control in the
G1 phase [29, 30]. Data from this study show that sig-
nificant activation of ATF3 (7.11-fold, p < 0.001) after
mHCN2 transfection in hMSCs can control the cell
cycle in the G1 phase and support better cell viability.
The strong activation of ATF3 might also show the for-
mation of functionally active mHCN2 channels which
are cAMP sensitive. Another factor important for the
control of the G1 phase is a general transcription factor
IIB (GTF2B), which stimulates transcription through the
stabilization of RNA polymerase II, initiating the DNA-
TBA (TATA-binding) complexes [31]. It was shown that
TF2B can also act as an autoacetyltransferase, which is
important for TFIIB acetylation, stabilization, and activa-
tion of cell transcription [32]. GTF2B activation is
mainly observed in the G1 phase, not in the M phase,
suggesting suppression of cell proliferation [33]. Our
data show that when GTF2B in mHCN2-transfected
hMSCs was activated 1.9-fold, G1 to S transition was de-
layed similarly to ATF3.
The helix-loop-helix protein ID1 is important for cell
“stemness” and is scarcely expressed in normal adult dif-
ferentiated tissues, whereas it is abundant in proliferat-
ing tissues [34]. Under low serum conditions, ectopic
expression of ID1, but not ID2, supported proliferation
Fig. 7 Intercellular coupling of cells growing on the opposite sides
of Kapton® scaffold. a DAPI (20 μM) was injected through the patch
pipette into the mHCN2-transfected cell 1 (nucleus encircled in c)
residing on the top side of Kapton® scaffold. b Non-transfected
hMSCs (cell 2 and cell 3) residing on the bottom side of the scaffold
(nucleus encircled in c). c Transfer of DAPI dye from the donor cell 1
to the recipient cell 2 and cell 3. Note that the fluorescence of
DAPI-stained nucleus in cell 1 could not be demonstrated because
of the impermeability of Kapton® scaffold to UV light. d DAPI
accumulation kinetics measured in the regions of interest (ROI)
situated on the nuclei of respective cells. Arrow indicates the onset
of dye application to cell 1
Bruzauskaite et al. Stem Cell Research & Therapy  (2016) 7:67 Page 12 of 15
of mammary epithelial cells [35]. Downregulation of
ID1, similar to c-Myc, decreased expression of cyclins
D1 and E. The same authors suggested that ID1 is
downstream of c-Myc in regulation of cell proliferation.
Consistent with this idea, both c-Myc and ID1 are ne-
cessary for sufficient G1 to S progression [36, 37]. An-
other transcription factor, the nuclear factor of activated
T cells (NFAT), belongs to a family of transcription fac-
tors that has been foremost identified in immune cells
and later on in a wide range of cell types and tissues [38,
39]. NFAT is constitutively expressed in resting cells,
whereas the activation of its receptor is related to the
mobilization of calcium and subsequent cell activation
[40]. It was also shown that calcium signals stimulate
progression of the cell cycle and promote transition of
the G1/S phase [41]. Our data show that ID1, c-Myc,
and NFATC3 were activated 1.86-, 2.3- and 1.6-fold
(p < 0.05), respectively, and could be involved in tran-
sition of the G1/S phase.
The last group of transcription factors controls the G2/
M phases. The TATA-binding protein (TBP) is a universal
transcription factor required for the eukaryotic RNA poly-
merase. TBP like-null chicken cells exhibited 20 % ele-
vated cell cycle progression due to shortening of the G2
phase [42], and TBP induces a delay in the G2/M transi-
tion which subsequently delays cell proliferation [43].
Moreover, TBP in stressed cells instead of transcription
regulation preferentially binds and repairs injured DNA
[44]. This study shows that 2.04-fold activation of TBP
after mHCN2 transfection may delay cell entrance to the
G2-M phase. On the other hand, the member of the E26
transformation-specific (ETS) family member ETS2, the
winged helix-turn-helix DNA-binding domain, has been
found to be a regulator of cdc2 expression necessary for
the G2/M phase and better cell growth under stress con-
ditions [45]. Moreover, ETS2 activation is necessary for
trophoblast stem cell self-renewal and is a vitally import-
ant factor for the survival of mouse embryos [46]. Data
from this study demonstrate that 2.79-fold ETS2 activa-
tion will slightly stimulate mHCN2-expressing cells to
proliferate, and might be important for better cell survival.
Conclusions
The results of this study show that mHCN2-transfected
hMSCs preserved high cell viability and functional activ-
ity necessary for cardiac stimulation: mHCN2-expressing
cells had low proliferative activity due to the downregu-
lation of the cell cycle and cell concentration in the G1
phase (~85 %); and generated If current and made
anchorage-dependent connection with other cells with-
out transmigration through a 12.7-μm thick Kapton® HN
film with micromachined 1–3 μm diameter pores. Insertion
of mHCN2 gene into hMSCs activates nine transcription
factors that control each phase of the cell cycle,
subsequently downregulating cell proliferation. The
strongest activation of cAMP-responsive transcription
factor ATF3 suggests its particular role in the G1 phase
arrest. Additionally, a strong activation of ATF3 in
mHCN2-transfected cells could be a marker of forma-
tion of functionally active HCN channels which are
also cAMP-dependent. This study shows that mHCN2-
transfected BM-derived hMSCs are appropriate for the
further generation of functional biopacemakers.
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